NCT02972580View on ClinicalTrials.gov

Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Duchenne Muscular DystrophyBecker Muscular Dystrophy
Interventions
GENETIC

Genetic characterization

Confirmatory genetic testing for mutation in DMD gene (Carrier Status) for subjects in respective Cohorts

Trial Locations (1)

43205

Nationwide Children's Hosptial, Columbus

All Listed Sponsors
collaborator

Parent Project Muscular Dystrophy

OTHER

lead

Nationwide Children's Hospital

OTHER

NCT02972580 - Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD | Biotech Hunter | Biotech Hunter